P2RX1 and acute lymphoblastic leukemia: An integrated analysis of mutant gene enrichment in ATP-binding pathways and differential expression profiling, identifying P2RX1 downregulation in the poor prognosis cohort, suggested that P2RX1 dysfunction may critically contribute to leukemogenesis and adverse clinical outcomes in Ph+/Ph-like ALL.